Cargando…
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
The ability of viruses to mutate and evade the human immune system and neutralizing antibodies remains an obstacle to antiviral and vaccine development. Many neutralizing antibodies, including some approved for emergency use authorization (EUA), reduced or lost activity against severe acute respirat...
Autores principales: | Shan, Sisi, Luo, Shitong, Yang, Ziqing, Hong, Junxian, Su, Yufeng, Ding, Fan, Fu, Lili, Li, Chenyu, Chen, Peng, Ma, Jianzhu, Shi, Xuanling, Zhang, Qi, Berger, Bonnie, Zhang, Linqi, Peng, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931377/ https://www.ncbi.nlm.nih.gov/pubmed/35238654 http://dx.doi.org/10.1073/pnas.2122954119 |
Ejemplares similares
-
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
por: Li, Mingxi, et al.
Publicado: (2022) -
SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
por: Wang, Ruoke, et al.
Publicado: (2022) -
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021) -
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
por: Ju, Bin, et al.
Publicado: (2023) -
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
por: Zhou, Panpan, et al.
Publicado: (2019)